Life Science Diplomacy Alliance
Snow-covered Estonian coastline beside the Baltic Sea in winter

About the alliance

The trusted international operating corridor across life science, healthcare, capital, and policy.

Connecting individuals, shaping emerging opportunities, and aligning resources for real-world challenges in 2027 and beyond

The operating layer

Coordination on an unprecedented scale for unprecedented times

The LSDA is designed for a world in which international cooperation becomes more selective, fragmented and unpredictable—not by retreating into regional self-sufficiency, but by making trusted cooperation more resilient.

Institutions built to push science, capital, healthcare, policy, and international cooperation are increasingly challenged to coordinate all those boundaries at once.

Governments can set policy. Universities generate knowledge. Investors allocate capital. Companies productize and scale. Hospitals validate and implement. Diplomats maintain formal relationships. Traditional science diplomacy institutes and think tanks provide strategy.

But major opportunities routinely sit between those mandates.

The LSDA is the operating layer that allows regional and disciplinary siloes to collaborate in a less predictable time.

Industry

The LSDA enables industry to fill the gaps between Science Diplomacy, Academia, and Innovation—and in a way that allows those organizations to play to their strengths as the world changes.

The organizations that are built to get products from “bench to bedside” know how to cross borders, follow regulatory guidelines, and operationalize clinical thinking. The LSDA is building the operating system that makes international cooperation more resilient under stress by equipping industry to operate in spaces traditionally reserved for science diplomacy.

Industry moves the machinery where science becomes capability.

Innovation geographies

Connected innovation

Regional ecosystems connect places to places.

The LSDA connects capability to actual need.

Our geographies follow innovation, not administrative borders, and then shape opportunities by the realities of governance, regulatory, and reimbursement.

World map showing LSDA regions across the Americas, Europe and Pacific allies

  • North of America

    Boston–Cambridge; NYC/​NJ; Philadelphia; Baltimore/​DC; Toronto–Waterloo; Montréal

  • Middle of America

    Minneapolis; Chicago; Detroit/​Ann Arbor; Cleveland; Pittsburgh; St. Louis; Madison; Alberta

  • West of America

    Texas; Bay Area; San Diego; LA/​Orange County; Seattle; Vancouver; Salt Lake; Denver/​Phoenix

  • South of America

    Research Triangle; Atlanta; Florida/​Miami; Mexico City/​Monterrey; São Paulo

  • New Nordics

    Denmark; Sweden; Norway; Finland; Estonia; Latvia; Lithuania; Iceland

  • DACH

    Basel–Zürich; Munich; Rhine-Neckar; Frankfurt; Vienna; German-speaking clusters

  • Benelux+

    Amsterdam/​Leiden/​Utrecht/​Eindhoven; Belgium; Luxembourg; Paris/​Lille

  • Mediterranean

    Lyon/​Marseille; Barcelona/​Madrid; Portugal; Italy; Greece; Cyprus; Malta; Israel

  • UK & Ireland

    London–Oxford–Cambridge; Manchester; Edinburgh/​Glasgow; Dublin

  • CEE

    Poland; Czechia; Slovakia; Hungary; Romania; Bulgaria; Slovenia/​Croatia; Serbia/​Balkans; Ukraine; Moldova; Eastern German nodes

  • Pacific Allies

    Australia; New Zealand; Japan; South Korea; Singapore

Governance

Light structure. Clear ownership.

01

Working group co-chairs

Two co-chairs from different functions and regions; elected for renewable 12-month terms without consecutive terms in the same role.
02

Regional stewards

Eighteen-month terms focused on outbound bridges, underused capability and a small number of meaningful relationships.
03

Partners-in-residence

Twelve-month operating roles that bring a needed lens, relationships and active participation.
04

Advisors

A small, non-operating bench serving two-year renewable terms for judgment, challenge and selective door-opening.

Working groups

The interesting information lives at the intersections.

Six working groups act as sensors to detect recurring system failures through the lens of their area. What are we seeing that shouldn’t be happening? What is shifting — and is it part of a broader signal? And, most importantly, what does this inform next?

Our working groups get early insight, share candid hypotheses, identify potential interventions or pivots, and help shape LSDA opportunities, summits, and meeting provocations.

01

Precision medicine & genomics

  1. Provocation #1

    What if a company could bring one research question and assemble the right cohorts, data and expertise across allied countries into a workable study?

  2. Provocation #2

    How can international investment advance a genomic discovery while building lasting scientific and economic value in its originating ecosystem?

02

Oncology & early detection

  1. Provocation #1

    What if investment in early detection included a funded pathway from a positive test to diagnosis and treatment?

  2. Provocation #2

    Which promising cancer discoveries could reach their next milestone with a development partner across the Atlantic—and what is preventing that partnership?

03

Women’s health

  1. Provocation #1

    What if sex and life-stage differences became a routine design and validation requirement across cardiovascular, neurological and diagnostic innovation?

  2. Provocation #2

    What evidence could women’s-health innovators, clinicians and patients build together that individual organisations cannot justify funding alone?

04

Cardiometabolic & renal

  1. Provocation #1

    What if every cardiovascular or renal pilot began with a named buyer and a defined decision about adoption?

  2. Provocation #2

    What evidence should a cardiovascular or renal technology be able to carry across the Atlantic—and what needs to be demonstrated again locally?

05

Neurology & mental health

  1. Provocation #1

    What if brain-health technologies were evaluated on daily function, independence and participation alongside clinical measures?

  2. Provocation #2

    What if US and European teams designed neurological validation studies together before market entry, creating useful evidence and development opportunities on both sides?

06

Prevention & wellness

  1. Provocation #1

    How can prevention become a fundable service when its costs and benefits fall on different organisations and timescales?

  2. Provocation #2

    What if useful risk signals from screening, wearables and predictive tools came with an accessible next step and someone accountable for follow-through?

Core functional participation within each working group, tailored to the requirements of specific disease states and security pre-requisites

Research & TranslationClinical Validation & Health SystemsPolicy & RegulatoryCapital & InvestmentCommercialization & Market AccessManufacturing, Supply & InfrastructureData, AI & Digital Infrastructure

Culture

Principles of our culture

01

The relationship is the unit of change

Capability, trust and lived knowledge matter more than logos or pedigree.
02

Small rooms beat large audiences

Twenty people able to move something are worth more than 500 consuming content.
03

We organize around doing, not agreeing

Honest agendas, constraints, and priorities are where the tools of diplomacy work. Agreement without action creates institutional theater; shared action can create alignment afterward.
04

Always know who to call

Familiarity and shared memory become insurance when institutions face friction.
05

Credibility comes from outcomes, not branding or pedigree

We judge our work by the consequence of it, not the prestige or views.
06

Operational beats ceremonial

Trust is in short supply now; we create the certainty, develop signed guardrails, and shape commitments.
07

Everyone enters as an equal

Titles, institutions, and seniority are left at the door. We have different roles and actions, but we all have a voice at the table.
08

Gravity does not require seriousness

People often do their most serious work once they stop performing seriousness.
09

Don’t resolve everything before beginning

Good people inside a sufficiently good structure will generate information planning alone can’t.
10

Capital is a diplomatic instrument

Economic and scientific diplomacy are our instruments for shared resilience, progress, and prosperity
All meetings and summits are held under Chatham House Rule. All members agree to a Code of Conduct.